Antimicrobial Susceptibility Testing Update - SWACM

More documents

Recommendations

Info

E. coli, Klebsiella spp., Proteus mirabilis% ESBL positiveE. coliOrganismK. oxytocaK. pneumoniaeP. mirabilisN*4601167939474% ESBL positive3.33.54.10.4*One isolate / patientUCLA 2009
E. coli, Klebsiella spp., Proteus mirabilisESBL positiveE. coliOrganismK. oxytocaK. pneumoniaeP. mirabilis108382*based on disk diffusion testingN3# patients with ESBL positiveisolates that tested S to:*CTAXCTAZCTAX & CTAZ1 133-1-• 20/151 = 13.2% ESBL positive isolates would test “S” tocefotaxime (CTAX) or ceftazidime (CTAZ) or both with new BPs- 16/20 isolates were from urine--11--UCLA 2/1/10 – 6/30/10
Page 1 and 2: Antimicrobial SusceptibilityTesting
Page 3 and 4: CLSI AST StandardsAugust 2010M100-S
Page 5: Ceftriaxone Prescribing Information
Page 8 and 9: Enterobacteriaceae - Cephalosporins
Page 10 and 11: Table 2A Enterobacteriaceae♦ Dosi
Page 12 and 13: Why did CLSI lower cephalosporin,az
Page 14 and 15: Old ParadigmEmergence of a new β-l
Page 16 and 17: www.eucast.org
Page 18 and 19: MEROPENEM MIC distribution exampleB
Page 20 and 21: PK-PD PD Goal (“Target(Target”)
Page 22 and 23: Factors that Affect PK-PDPDTarget A
Page 24 and 25: What PK-PD PD data were used torevi
Page 26 and 27: Probability of Target AttainmentImi
Page 28 and 29: ImipenemProbability ofTarget Attain
Page 30 and 31: Enterobacteriaceae% Capture of Carb
Page 32 and 33: Meropenem MIC DistributionsEnteroba
Page 34 and 35: Expected Results forCarbapenemase-P
Page 36 and 37: Cumulative Ceftriaxone MIC Distribu
Page 38 and 39: Ceftriaxone MIC DistributionC. freu
Page 42 and 43: Expected Results forESBL-ProducersC
Page 44 and 45: Why was cefepime breakpoint notlowe
Page 46 and 47: Why did cephalothin get moved?As re
Page 48 and 49: What narrow-spectrum cephalosporin
Page 50 and 51: Brief CLSI and FDABreakpoint (BP) S
Page 52 and 53: Steps to ImplementingNew CLSI Cepha
Page 54 and 55: Status of New Breakpoint Concentrat
Page 56 and 57: Some concerns about the newbreakpoi
Page 58 and 59: http://www.clsi.org/Content/Navigat

Antimicrobial Susceptibility Testing Update - SWACM

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?